Getting ready to finish cancer treatment and want to know what is next? Finished cancer treatment and want to be sure you know what you should be doing for follow-up? A Survivorship Care Plan can help.
What’s a care plan? It’s a roadmap to guide your cancer care following your diagnosis and treatment of cancer. People who have completed treatment of melanoma or are currently in treatment can develop a care plan with their health care team. A care plan can:
• Detail your diagnosis
• Outline the treatments you have had or are currently taking
• Tell you who on your health care team to contact with questions or concerns
• Explain symptoms or side effects you might experience and who to call if you need help managing them
• Outline what you should do and who you should see for follow-up care
Watch the webinar, Frankly Speaking About Cancer: Survivorship Care Planning that took place on August 30, 2016, for information on survivorship care planning. This webinar shows from a social worker and a survivor’s point of view. The presentation is followed by a question and answer period with the speakers. This webinar uses a Melanoma Survivorship Care Plan, as well as a generic Cancer Survivorship Care Plan, so it will be of special interest to melanoma survivors. Survivorship care planning is a great step for survivors and caregivers who are about to finish active treatment of their cancer.
The webinar features the following panelists:
• Rosie Morrison, LLMSW, Program Director at the Cancer Support Community of Greater Ann Arbor
• Donna Piunt, Melanoma Survivor
• Kim Ziner, PhD, RN, CBCN, ACNS-BC, Clinical Nurse Specialist at Franciscan St. Francis Health, Indianapolis, IN
For more information about cancer survivorship, please visit:
[ Ссылка ]
This program is made possible with support from Bristol-Myers Squibb.
0:00 Introduction and CSC Resources
4:10 Today’s Speakers
6:38 Cancer Survivorship
8:17 Healthy Lifestyle
10:11 Emotional Health
12:00 Focus on Survivorship
15:43 Roadmap for Survivorship
22:53 Care Plans
28:07 Patient Perspective
37:07 Audience Q&A
1:30:45 Learn More
